The complete library

Articles and guides

Explore 51 source-based articles on medication, dosing, safety, access, and metabolic health. Updated October 2, 2026.

Medical review is pending. These articles help you understand evidence and prepare questions; they do not choose a treatment or dose. How we check content.

Search articlesFilter by topicAllAccessDosingMedicationMetabolic healthSafety

51 results

DosingMounjaro dosage chart: a guide to the labelAdult Mounjaro dosing, titration, missed-dose rules, and the difference between diabetes and weight-management prescribing.DosingZepbound dosage chart: a guide to the labelZepbound's weekly escalation and different maintenance doses for weight management and obstructive sleep apnea.DosingOzempic dosage chart: a guide to the labelOzempic injection doses for diabetes, kidney-risk reduction, and product-specific missed-dose instructions.DosingWegovy injection dosage chart: a guide to the labelWegovy injection titration, indication-specific maintenance, missed doses, and the separate Wegovy HD option.DosingSemaglutide dosage charts: injection and oral productsCompare Ozempic, Wegovy injection, Wegovy tablets, and Rybelsus without mixing up doses or syringe units.DosingWegovy pill dosage chart and daily instructionsThe 1.5 mg, 4 mg, 9 mg, and 25 mg Wegovy tablet schedule, fasting instructions, and missed-dose rule.MedicationSemaglutide review: benefits, formulations, and limitsAn evidence-based guide to semaglutide's glucose effects, approved products, clinical benefits, and safety limitations.MedicationTirzepatide review: glucose, weight, and approved usesHow tirzepatide's GIP and GLP-1 activity relates to Mounjaro, Zepbound, clinical results, and safety.MedicationIs semaglutide the same as Ozempic?Understand the difference between an active ingredient, brand, approved formulation, and compounded product.MedicationWegovy pill FDA approval: what is current in 2026Updated oral Wegovy approval coverage, adult indications, dosing, and a correction to old launch and trial claims.MedicationWegovy pill review: evidence and everyday tradeoffsReview oral Wegovy's fasting routine, trial evidence, safety, cost, and differences from other oral GLP-1 options.MedicationWhich GLP-1 is best for weight loss? Compare the evidenceCompare semaglutide, tirzepatide, newer oral options, and the limits of trial-based rankings.MedicationOzempic tablets: the oral diabetes product and its dosingOzempic tablets' 1.5 mg, 4 mg, and 9 mg strengths, diabetes and cardiovascular indications, and distinction from Rybelsus and Wegovy.MedicationFoundayo review: orforglipron's approved role in 2026Foundayo's FDA approval, daily routine, dose escalation, medicine interactions, and safety limitations.DosingFoundayo dosage chart: initiation, escalation, and interactionsThe labeled orforglipron titration steps, daily administration, missed tablets, and important dose-limiting interactions.MedicationWegovy HD 7.2 mg: the new injection optionWhat Wegovy HD adds, who the labeled dose is for, escalation requirements, and why prior comparison trials do not rank it.MedicationOral GLP-1 comparison: Wegovy, Foundayo, and RybelsusCompare approved oral GLP-1 products by ingredient, indication, administration, and safety rather than treating them as interchangeable pills.MedicationRybelsus review: oral semaglutide for diabetesRybelsus' separate diabetes role, formulation-specific tablet strengths, fasting routine, and distinction from oral Wegovy.MedicationSaxenda review: liraglutide and daily weight-management careSaxenda's daily injection, labeled escalation, response assessment, and why liraglutide products need exact identification.DosingWhere to inject semaglutide: approved sites and techniqueThe labeled injection sites for Ozempic and Wegovy, rotation, device instructions, and why site choice does not guarantee better results.DosingWhere to inject tirzepatide: approved sites and techniqueThe labeled injection sites for Mounjaro and Zepbound, rotation, device instructions, and why site choice does not guarantee better results.DosingBest time to take semaglutide: consistency and label rulesWeekly semaglutide timing, food considerations, changing the dosing day, and the difference between anecdotes and evidence.DosingBest time to take tirzepatide: consistency and label rulesWeekly tirzepatide timing, food considerations, changing the dosing day, and the difference between anecdotes and evidence.DosingWhen to take tirzepatide after travel, a late dose, or a schedule changeApply tirzepatide's 96-hour missed-dose window and 72-hour spacing rule without accidentally doubling treatment.DosingMissed GLP-1 dose guide: rules differ by productCompare late-dose rules for Ozempic, Wegovy injection and tablets, and tirzepatide; plan prolonged restarts with a clinician.SafetyGLP-1 dosing safety: mg, mL, and syringe unitsWhy dose, concentration, volume, and syringe markings must be kept separate when using a GLP-1 vial.DosingTravel with GLP-1 medicines: storage and schedule checksPrepare for travel by checking the exact product's temperature limits, presentation, supplies, and weekly timing.AccessBuying semaglutide online: products, prescription, and pharmacy checksA safe access guide to Ozempic, Wegovy injections and tablets, Rybelsus, and compounded semaglutide claims.AccessBuying tirzepatide online: Mounjaro, Zepbound, and sourcingCompare tirzepatide access routes without confusing a compounded product with Mounjaro or Zepbound.AccessHow to compare online semaglutide programsCompare approved-product access, care fees, pharmacy costs, oral options, and follow-up rather than unsupported provider ratings.AccessHow to compare online tirzepatide programsA practical comparison of tirzepatide clinical access, Mounjaro and Zepbound indications, pharmacy sourcing, and total costs.AccessWhere to get tirzepatide: clinic, pharmacy, or access programCompare local care, telehealth, and manufacturer pharmacy routes for tirzepatide with sourcing and continuity checks.AccessCompounding pharmacies for semaglutide: what to verify nowUpdated semaglutide compounding guidance after shortage resolution, with pharmacy, prescription, and dosing checks.AccessCompounding pharmacies for tirzepatide: what to verify nowUpdated tirzepatide compounding guidance after shortage resolution, with pharmacy, prescription, and dosing checks.SafetyCompounded GLP-1 safety and current FDA concernsUnderstand approval status, shortage-era restrictions, salt forms, dosing errors, and why additives do not establish equivalence.AccessGLP-1 cost and insurance: build a complete budgetSeparate care membership, medication, labs, supplies, introductory offers, and prior authorization when comparing GLP-1 treatment.AccessTelehealth GLP-1 checklist: before enrollment and after dispensingA practical checklist for product identity, state-licensed care, pharmacy sourcing, fees, follow-up, and dosing instructions.SafetyWhy can Mounjaro cause diarrhea? Symptoms and when to get helpUnderstand diarrhea during tirzepatide treatment, dehydration concerns, dose escalation, and symptoms needing medical care.SafetySulfur burps on Mounjaro: what is known and what is uncertainSeparate recognized burping and reflux symptoms from unproven sulfur-burp explanations and internet remedies.SafetyGLP-1 side effects: common symptoms and serious warning signsA product-aware guide to digestive side effects, dehydration, hypoglycemia, pancreatitis concerns, and clinical follow-up.SafetyGLP-1 medicines, pregnancy, and oral contraceptionProduct-specific pregnancy planning and the different oral contraceptive precautions for tirzepatide and Foundayo.SafetyGLP-1 medicines before surgery or sedationWhy delayed gastric emptying matters for anesthesia, what information to share, and why a universal hold rule is insufficient.SafetyGLP-1 microdosing: separate marketing from evidenceWhat to ask about low-dose GLP-1 offers, approved starter doses, prevention claims, and formulation-specific evidence.SafetyRetatrutide status: research is not a prescription approvalUnderstand the difference between investigational retatrutide research and unapproved products sold online.Metabolic healthWeight loss with GLP-1 medicines: evidence and a sustainable care planUnderstand treatment eligibility, mechanism, realistic trial interpretation, nutrition, follow-up, and what can happen after stopping.Metabolic healthBlood tests during GLP-1 care: what each result can tell youA clinician-focused guide to HbA1c, glucose, kidney measures, lipids, and choosing tests by medical need.Metabolic healthStopping GLP-1 treatment: weight regain and continuing careWhat the STEP 1 extension shows about stopping semaglutide, and how to discuss access, follow-up, and restart planning.Metabolic healthNutrition and muscle during GLP-1 weight managementPlan adequate nourishment, activity, and support during reduced appetite without promising a universal protein target or perfect muscle preservation.Metabolic healthGLP-1 heart and kidney benefits: match the label to the patientUnderstand why cardiovascular and kidney-risk reduction belong to specific medicines, indications, and populations.Metabolic healthZepbound and obstructive sleep apnea: the approved roleZepbound's moderate-to-severe OSA indication in adults with obesity, maintenance dosing, and continuing sleep care.Metabolic healthWegovy and MASH: an indication with important limitsWegovy injection's noncirrhotic MASH indication, fibrosis criteria, accelerated approval, and why tablets or HD claims should not be generalized.